Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-02-23 @ 8:07 PM
Study NCT ID:
NCT02319135
Status:
COMPLETED
Last Update Posted:
2020-04-06
First Post:
2014-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Azacytidine (Vidaza®) Versus Fludarabine and Cytarabine (Fluga Scheme) in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
PETHEMA Foundation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-10
First Submit QC Date:
None
Study First Post Date:
2014-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-03
Last Update Post Date:
2020-04-06
Last Update Post Date Type:
ACTUAL